Page last updated: 2024-11-07

guan-fu base a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Guan-fu base A: an anti-arrhythmia agent; isolated from the tuber of Aconitum doreanum; RN given refers to (2alpha,11alpha,13R)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AconitumgenusA plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.[MeSH]RanunculaceaeThe buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH]

Cross-References

ID SourceID
PubMed CID101603171
MeSH IDM0120862

Synonyms (4)

Synonym
guanfu base a
guan-fu base a
[(1s,3s,5s,8s,9r,11r,14r,16s,17r,18s,19s)-10-acetyloxy-9,19-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-3-yl] acetate
AKOS040759326

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Safety evaluation revealed that ear vein injection of GFASN (14 mg/kg) were safe enough and of good biocompatibility."( Safety, heart specificity, and therapeutic effect evaluation of Guanfu base A-loaded solid nanolipids in treating arrhythmia.
Chen, J; Gu, N; Liu, J; Liu, K; Liu, S; Wang, H; Xiong, F, 2018
)
0.48

Pharmacokinetics

ExcerptReferenceRelevance
"To establish an analytical method for determination of guanfu base A (GFA) concentration in plasma and to study its pharmacokinetic profile in dogs."( [Determination of guanfu base A hydrochloride in plasma by LC-MS method and its pharmacokinetics in dogs].
Cai, XH; Liu, JH; Sun, JG; Wang, GJ; Wu, MS, 2002
)
0.31
" Pharmacokinetic evaluation was carried out using the 3P87 program."( [Determination of guanfu base A hydrochloride in plasma by LC-MS method and its pharmacokinetics in dogs].
Cai, XH; Liu, JH; Sun, JG; Wang, GJ; Wu, MS, 2002
)
0.31
"The analytical method was shown to be sensitive, specific, rapid and reproducible, and was suitable for pharmacokinetic studies of GFA."( [Determination of guanfu base A hydrochloride in plasma by LC-MS method and its pharmacokinetics in dogs].
Cai, XH; Liu, JH; Sun, JG; Wang, GJ; Wu, MS, 2002
)
0.31
" This quantitation method was successfully applied to the simultaneous determination of GFA and its metabolites in human plasma for the metabolic study and pharmacokinetic evaluation."( Simultaneous determination of GFA and its active metabolites in human plasma by liquid chromatography electrospray ionization mass spectrometry and its application to pharmacokinetic studies.
A, JY; Gu, SH; Huang, Q; Liu, LS; Ren, HC; Sun, JG; Wang, GJ; Yan, B; Zha, WB; Zhang, JW; Zhang, Y, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" The absolute bioavailability of GFI was 71."( Pharmacokinetics of guanfu base I, an active metabolite of guanfu base A, in rats.
Li, X; Liu, J; Sun, J; Wang, G; Wang, S, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (11.43)18.7374
1990's11 (31.43)18.2507
2000's10 (28.57)29.6817
2010's8 (22.86)24.3611
2020's2 (5.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.56%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]